Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorodeoxyglucose F18 | 66 | 2024 | 2004 | 8.370 |
Why?
|
Arteritis | 22 | 2024 | 159 | 8.310 |
Why?
|
Positron-Emission Tomography | 73 | 2024 | 6457 | 4.650 |
Why?
|
Radiopharmaceuticals | 48 | 2024 | 2634 | 4.530 |
Why?
|
Atherosclerosis | 44 | 2024 | 3401 | 4.290 |
Why?
|
Plaque, Atherosclerotic | 24 | 2023 | 1505 | 3.080 |
Why?
|
Amygdala | 10 | 2024 | 1351 | 2.230 |
Why?
|
Noise, Transportation | 3 | 2022 | 51 | 2.200 |
Why?
|
Molecular Imaging | 8 | 2024 | 815 | 2.060 |
Why?
|
Inflammation | 35 | 2024 | 10719 | 1.870 |
Why?
|
Cardiovascular Diseases | 21 | 2024 | 15396 | 1.830 |
Why?
|
Aorta, Thoracic | 8 | 2021 | 1094 | 1.730 |
Why?
|
Aortitis | 6 | 2020 | 74 | 1.720 |
Why?
|
Carotid Artery Diseases | 11 | 2024 | 872 | 1.720 |
Why?
|
Coronary Artery Disease | 25 | 2024 | 6363 | 1.620 |
Why?
|
Cardiovascular System | 3 | 2024 | 835 | 1.370 |
Why?
|
Stress, Psychological | 9 | 2024 | 4457 | 1.290 |
Why?
|
Editorial Policies | 2 | 2023 | 456 | 1.280 |
Why?
|
Myocardial Perfusion Imaging | 6 | 2024 | 570 | 1.240 |
Why?
|
Pyrroles | 4 | 2015 | 1130 | 1.170 |
Why?
|
Heptanoic Acids | 3 | 2014 | 344 | 1.160 |
Why?
|
Periodontal Diseases | 3 | 2019 | 451 | 1.140 |
Why?
|
Carotid Stenosis | 6 | 2016 | 853 | 1.120 |
Why?
|
Coronary Vessels | 10 | 2023 | 3072 | 1.110 |
Why?
|
Venous Thrombosis | 6 | 2024 | 1292 | 1.110 |
Why?
|
Tomography, X-Ray Computed | 34 | 2024 | 20500 | 1.090 |
Why?
|
Anti-Inflammatory Agents | 10 | 2023 | 1793 | 1.090 |
Why?
|
Publishing | 2 | 2023 | 833 | 1.070 |
Why?
|
HIV Infections | 16 | 2024 | 17275 | 1.000 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 608 | 1.000 |
Why?
|
Bone Marrow | 6 | 2021 | 2909 | 0.990 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2022 | 3227 | 0.970 |
Why?
|
Arthritis, Rheumatoid | 6 | 2024 | 3755 | 0.920 |
Why?
|
Carotid Arteries | 6 | 2021 | 939 | 0.890 |
Why?
|
Predictive Value of Tests | 31 | 2023 | 15225 | 0.880 |
Why?
|
Social Class | 3 | 2022 | 1999 | 0.860 |
Why?
|
Aorta | 8 | 2021 | 2037 | 0.850 |
Why?
|
Heart | 10 | 2024 | 4382 | 0.850 |
Why?
|
Arteries | 5 | 2019 | 1125 | 0.820 |
Why?
|
Coronary Circulation | 7 | 2007 | 1561 | 0.800 |
Why?
|
Hematopoiesis | 5 | 2019 | 2047 | 0.780 |
Why?
|
Takayasu Arteritis | 1 | 2023 | 97 | 0.770 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2024 | 269 | 0.770 |
Why?
|
Sodium Fluoride | 2 | 2021 | 62 | 0.740 |
Why?
|
Aortic Diseases | 4 | 2015 | 735 | 0.730 |
Why?
|
Aortography | 5 | 2020 | 420 | 0.730 |
Why?
|
Humans | 160 | 2024 | 758381 | 0.710 |
Why?
|
Lighting | 1 | 2022 | 211 | 0.700 |
Why?
|
Spleen | 4 | 2021 | 2296 | 0.700 |
Why?
|
Calcinosis | 2 | 2021 | 1467 | 0.660 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 123 | 0.660 |
Why?
|
Adiposity | 3 | 2019 | 1858 | 0.660 |
Why?
|
Macrophages | 8 | 2018 | 5737 | 0.650 |
Why?
|
Autonomic Nervous System | 1 | 2024 | 697 | 0.650 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 297 | 0.630 |
Why?
|
Fluorides | 1 | 2019 | 134 | 0.620 |
Why?
|
Risk Factors | 38 | 2024 | 73806 | 0.610 |
Why?
|
C-Reactive Protein | 7 | 2024 | 3812 | 0.600 |
Why?
|
Vasculitis | 7 | 2024 | 522 | 0.590 |
Why?
|
Middle Aged | 80 | 2024 | 219560 | 0.590 |
Why?
|
Air Pollutants | 2 | 2022 | 2842 | 0.590 |
Why?
|
Male | 99 | 2024 | 358742 | 0.580 |
Why?
|
Edema, Cardiac | 1 | 2016 | 19 | 0.540 |
Why?
|
Lymphadenitis | 1 | 2017 | 98 | 0.530 |
Why?
|
Methotrexate | 5 | 2024 | 1719 | 0.520 |
Why?
|
Obesity, Abdominal | 1 | 2019 | 374 | 0.520 |
Why?
|
Fluorine Radioisotopes | 4 | 2022 | 413 | 0.510 |
Why?
|
Stroke | 6 | 2023 | 9696 | 0.510 |
Why?
|
Phosphofructokinase-2 | 1 | 2015 | 32 | 0.500 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 451 | 0.500 |
Why?
|
Female | 90 | 2024 | 390316 | 0.490 |
Why?
|
Vasodilation | 4 | 2005 | 960 | 0.490 |
Why?
|
Brain Ischemia | 3 | 2023 | 3047 | 0.480 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 685 | 0.480 |
Why?
|
Contrast Media | 7 | 2016 | 5298 | 0.470 |
Why?
|
Aged | 53 | 2024 | 168217 | 0.470 |
Why?
|
Environment | 1 | 2020 | 1118 | 0.460 |
Why?
|
Coronary Angiography | 12 | 2023 | 4451 | 0.460 |
Why?
|
Pericardial Effusion | 1 | 2016 | 247 | 0.450 |
Why?
|
Adipose Tissue, Brown | 3 | 2016 | 755 | 0.440 |
Why?
|
Rubidium Radioisotopes | 1 | 2013 | 76 | 0.430 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 81 | 0.430 |
Why?
|
Stress, Physiological | 1 | 2020 | 1398 | 0.430 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2013 | 127 | 0.430 |
Why?
|
Triazines | 1 | 2015 | 310 | 0.430 |
Why?
|
Interleukin-1beta | 1 | 2018 | 996 | 0.420 |
Why?
|
Environmental Pollutants | 1 | 2022 | 1268 | 0.420 |
Why?
|
Double-Blind Method | 19 | 2024 | 12262 | 0.410 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 886 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 14 | 2024 | 36285 | 0.410 |
Why?
|
Vasodilator Agents | 4 | 2005 | 973 | 0.410 |
Why?
|
CD4 Lymphocyte Count | 7 | 2024 | 2569 | 0.400 |
Why?
|
Lipids | 3 | 2024 | 3326 | 0.400 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2024 | 4562 | 0.390 |
Why?
|
Rabbits | 9 | 2021 | 4771 | 0.390 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 640 | 0.380 |
Why?
|
Synovial Membrane | 1 | 2014 | 524 | 0.380 |
Why?
|
DNA, Viral | 2 | 2024 | 2194 | 0.380 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 611 | 0.380 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12076 | 0.370 |
Why?
|
Myocarditis | 2 | 2016 | 766 | 0.370 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1256 | 0.360 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2021 | 8946 | 0.360 |
Why?
|
Aortic Valve Stenosis | 2 | 2014 | 2002 | 0.360 |
Why?
|
Risk Assessment | 14 | 2022 | 23883 | 0.360 |
Why?
|
Radionuclide Imaging | 4 | 2023 | 1975 | 0.350 |
Why?
|
Adult | 43 | 2024 | 219916 | 0.340 |
Why?
|
Angina Pectoris | 2 | 2013 | 959 | 0.340 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2551 | 0.340 |
Why?
|
Sulfonylurea Compounds | 1 | 2011 | 219 | 0.340 |
Why?
|
HIV | 1 | 2017 | 1581 | 0.340 |
Why?
|
Anxiety | 1 | 2024 | 4538 | 0.330 |
Why?
|
Longitudinal Studies | 8 | 2020 | 14481 | 0.330 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 112 | 0.330 |
Why?
|
Sulfhydryl Compounds | 5 | 2016 | 297 | 0.330 |
Why?
|
Tomography, Optical | 1 | 2010 | 129 | 0.320 |
Why?
|
Infarction | 2 | 2022 | 247 | 0.320 |
Why?
|
Thiazolidinediones | 1 | 2011 | 460 | 0.310 |
Why?
|
Myocardial Ischemia | 4 | 2013 | 2108 | 0.300 |
Why?
|
Inflammation Mediators | 5 | 2019 | 1878 | 0.300 |
Why?
|
Retrospective Studies | 19 | 2024 | 80170 | 0.300 |
Why?
|
Psoriasis | 3 | 2021 | 938 | 0.300 |
Why?
|
Receptors, Scavenger | 1 | 2007 | 123 | 0.290 |
Why?
|
Glucose Intolerance | 1 | 2011 | 575 | 0.290 |
Why?
|
Acute Coronary Syndrome | 4 | 2015 | 2180 | 0.290 |
Why?
|
Ethanol | 2 | 2023 | 1325 | 0.280 |
Why?
|
Air Pollution | 1 | 2021 | 2314 | 0.280 |
Why?
|
Veins | 2 | 2021 | 765 | 0.270 |
Why?
|
Ultrasonography, Doppler | 3 | 2018 | 463 | 0.270 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 9160 | 0.270 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7817 | 0.270 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 802 | 0.270 |
Why?
|
Whole Body Imaging | 2 | 2020 | 278 | 0.270 |
Why?
|
Time Factors | 15 | 2020 | 39873 | 0.270 |
Why?
|
Heart Diseases | 1 | 2019 | 2782 | 0.270 |
Why?
|
Brachial Artery | 2 | 2018 | 365 | 0.270 |
Why?
|
Photosensitizing Agents | 2 | 2007 | 618 | 0.260 |
Why?
|
Sensitivity and Specificity | 10 | 2017 | 14641 | 0.260 |
Why?
|
Magnetic Resonance Angiography | 2 | 2016 | 1431 | 0.260 |
Why?
|
Angina, Unstable | 1 | 2010 | 887 | 0.260 |
Why?
|
Arteriosclerosis | 3 | 2006 | 1055 | 0.260 |
Why?
|
Neutrophils | 2 | 2015 | 3765 | 0.250 |
Why?
|
Serum Albumin, Bovine | 1 | 2006 | 322 | 0.250 |
Why?
|
Lymph Nodes | 1 | 2017 | 3485 | 0.250 |
Why?
|
Reproducibility of Results | 8 | 2017 | 20052 | 0.250 |
Why?
|
Aortic Valve | 1 | 2014 | 1950 | 0.240 |
Why?
|
HIV-1 | 3 | 2024 | 6850 | 0.240 |
Why?
|
Depression | 1 | 2024 | 8057 | 0.240 |
Why?
|
Myocardium | 4 | 2018 | 4690 | 0.230 |
Why?
|
Thrombosis | 2 | 2015 | 2929 | 0.230 |
Why?
|
Prognosis | 9 | 2023 | 29558 | 0.230 |
Why?
|
Prospective Studies | 15 | 2023 | 54136 | 0.230 |
Why?
|
Phospholipids | 2 | 2020 | 784 | 0.230 |
Why?
|
Regional Blood Flow | 2 | 2005 | 1486 | 0.230 |
Why?
|
Porphyrins | 1 | 2006 | 352 | 0.220 |
Why?
|
Angioscopy | 1 | 2003 | 47 | 0.220 |
Why?
|
Image Enhancement | 2 | 2016 | 2880 | 0.220 |
Why?
|
MERRF Syndrome | 1 | 2003 | 4 | 0.220 |
Why?
|
Antirheumatic Agents | 2 | 2024 | 1368 | 0.220 |
Why?
|
Blood Component Removal | 2 | 2014 | 132 | 0.220 |
Why?
|
Mitochondrial Myopathies | 1 | 2003 | 49 | 0.210 |
Why?
|
Central Nervous System Depressants | 1 | 2004 | 164 | 0.210 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3339 | 0.210 |
Why?
|
Disease Progression | 8 | 2021 | 13468 | 0.210 |
Why?
|
Incidence | 6 | 2024 | 21273 | 0.210 |
Why?
|
Treatment Outcome | 22 | 2024 | 64379 | 0.210 |
Why?
|
Heart Transplantation | 1 | 2016 | 3220 | 0.210 |
Why?
|
Epilepsies, Myoclonic | 1 | 2003 | 85 | 0.210 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2646 | 0.210 |
Why?
|
Tissue Distribution | 4 | 2016 | 2263 | 0.200 |
Why?
|
Coronary Artery Bypass | 2 | 2022 | 2189 | 0.200 |
Why?
|
Environmental Exposure | 3 | 2022 | 4411 | 0.200 |
Why?
|
Hyperhomocysteinemia | 1 | 2002 | 118 | 0.200 |
Why?
|
Phenotype | 1 | 2020 | 16534 | 0.200 |
Why?
|
Receptors, Somatostatin | 1 | 2023 | 136 | 0.200 |
Why?
|
Income | 2 | 2021 | 1872 | 0.200 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2022 | 56 | 0.200 |
Why?
|
Case-Control Studies | 12 | 2024 | 22031 | 0.200 |
Why?
|
Chest Pain | 3 | 2022 | 1090 | 0.190 |
Why?
|
Acidosis, Lactic | 1 | 2003 | 145 | 0.190 |
Why?
|
Glycolysis | 2 | 2016 | 826 | 0.190 |
Why?
|
Adenosine | 2 | 2005 | 802 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5629 | 0.190 |
Why?
|
Recombinant Proteins | 3 | 2016 | 6520 | 0.190 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 108 | 0.180 |
Why?
|
Periodontium | 1 | 2021 | 97 | 0.180 |
Why?
|
Leukopoiesis | 1 | 2020 | 55 | 0.180 |
Why?
|
Aorta, Abdominal | 2 | 2021 | 625 | 0.180 |
Why?
|
Boston | 5 | 2016 | 9304 | 0.180 |
Why?
|
Neurobiology | 1 | 2021 | 137 | 0.180 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.170 |
Why?
|
Animals | 23 | 2021 | 167777 | 0.170 |
Why?
|
Blood Circulation | 1 | 2021 | 249 | 0.170 |
Why?
|
Particulate Matter | 2 | 2022 | 2556 | 0.170 |
Why?
|
Heart Rate | 5 | 2024 | 4166 | 0.170 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 25953 | 0.170 |
Why?
|
Photochemotherapy | 1 | 2006 | 819 | 0.170 |
Why?
|
Crime | 1 | 2020 | 202 | 0.160 |
Why?
|
Fibrin | 1 | 2021 | 505 | 0.160 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4876 | 0.160 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15785 | 0.160 |
Why?
|
Brain | 4 | 2024 | 26951 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 465 | 0.160 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 3069 | 0.160 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 782 | 0.160 |
Why?
|
Piperazines | 2 | 2007 | 2511 | 0.160 |
Why?
|
Hematopoietic System | 1 | 2018 | 109 | 0.160 |
Why?
|
Endothelium, Vascular | 3 | 2021 | 4429 | 0.150 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12096 | 0.150 |
Why?
|
Folic Acid | 1 | 2005 | 1309 | 0.150 |
Why?
|
Acetaldehyde | 1 | 2018 | 39 | 0.150 |
Why?
|
Noise | 1 | 2020 | 280 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 878 | 0.150 |
Why?
|
Purines | 4 | 2023 | 605 | 0.150 |
Why?
|
Malondialdehyde | 1 | 2018 | 111 | 0.150 |
Why?
|
Prediabetic State | 1 | 2023 | 547 | 0.150 |
Why?
|
Electrons | 1 | 2019 | 264 | 0.150 |
Why?
|
Homocystine | 1 | 1997 | 21 | 0.150 |
Why?
|
Causality | 1 | 2023 | 1241 | 0.140 |
Why?
|
Epoxide Hydrolases | 1 | 2018 | 122 | 0.140 |
Why?
|
Chronic Disease | 3 | 2020 | 9266 | 0.140 |
Why?
|
Hypercholesterolemia | 2 | 2016 | 1139 | 0.140 |
Why?
|
Diagnostic Imaging | 3 | 2017 | 3526 | 0.140 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5105 | 0.140 |
Why?
|
Myocardial Contraction | 2 | 2007 | 1516 | 0.140 |
Why?
|
Endothelium | 1 | 2019 | 764 | 0.140 |
Why?
|
Tomography, Emission-Computed | 4 | 2003 | 1121 | 0.130 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 615 | 0.130 |
Why?
|
RNA, Viral | 1 | 2024 | 2836 | 0.130 |
Why?
|
Permeability | 1 | 2018 | 718 | 0.130 |
Why?
|
Follow-Up Studies | 9 | 2019 | 39060 | 0.130 |
Why?
|
Esters | 5 | 2016 | 209 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 781 | 0.130 |
Why?
|
Cell Death | 1 | 2020 | 1667 | 0.120 |
Why?
|
Cicatrix | 1 | 2021 | 781 | 0.120 |
Why?
|
Cathepsins | 1 | 2016 | 241 | 0.120 |
Why?
|
Viral Load | 3 | 2024 | 3321 | 0.120 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2015 | 93 | 0.120 |
Why?
|
Systems Integration | 1 | 2017 | 426 | 0.120 |
Why?
|
Radiographic Image Enhancement | 2 | 2010 | 875 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2023 | 3208 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2001 | 818 | 0.120 |
Why?
|
Rhamnose | 1 | 2014 | 18 | 0.120 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1705 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2022 | 5199 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6293 | 0.110 |
Why?
|
Asthma | 1 | 2013 | 6172 | 0.110 |
Why?
|
Sulfones | 2 | 2007 | 446 | 0.110 |
Why?
|
Amides | 5 | 2016 | 447 | 0.110 |
Why?
|
Troponin T | 2 | 2023 | 761 | 0.110 |
Why?
|
Hydroxyurea | 1 | 2015 | 282 | 0.110 |
Why?
|
Homocysteine | 1 | 1997 | 638 | 0.110 |
Why?
|
Cohort Studies | 7 | 2024 | 41252 | 0.110 |
Why?
|
Clavicle | 1 | 2016 | 224 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1541 | 0.110 |
Why?
|
Anticholesteremic Agents | 4 | 2016 | 963 | 0.110 |
Why?
|
Hypolipidemic Agents | 2 | 2014 | 609 | 0.110 |
Why?
|
Neural Pathways | 1 | 2024 | 3040 | 0.110 |
Why?
|
Pyrazoles | 1 | 2023 | 1990 | 0.110 |
Why?
|
Apolipoprotein A-I | 1 | 2014 | 294 | 0.100 |
Why?
|
Prevalence | 3 | 2020 | 15646 | 0.100 |
Why?
|
California | 1 | 2017 | 1419 | 0.100 |
Why?
|
Drugs, Investigational | 1 | 2014 | 212 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2015 | 656 | 0.100 |
Why?
|
Thoracic Arteries | 1 | 2012 | 40 | 0.100 |
Why?
|
Disease Models, Animal | 8 | 2021 | 18125 | 0.100 |
Why?
|
Particle Size | 1 | 2016 | 1641 | 0.100 |
Why?
|
Cholesterol, LDL | 4 | 2015 | 2374 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2023 | 1066 | 0.100 |
Why?
|
Exercise | 2 | 2024 | 5788 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2024 | 3100 | 0.100 |
Why?
|
Epitopes | 1 | 2018 | 2502 | 0.090 |
Why?
|
Iopamidol | 1 | 2011 | 186 | 0.090 |
Why?
|
Ultrasonography, Interventional | 2 | 2016 | 1489 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2023 | 3299 | 0.090 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1007 | 0.090 |
Why?
|
Cell Membrane | 1 | 2020 | 3680 | 0.090 |
Why?
|
Cyclopropanes | 1 | 2012 | 431 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2023 | 4020 | 0.090 |
Why?
|
Organ Specificity | 2 | 2006 | 1955 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1997 | 1486 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1214 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1196 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10747 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2019 | 1895 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3425 | 0.090 |
Why?
|
Iron | 1 | 2018 | 1786 | 0.090 |
Why?
|
Odds Ratio | 4 | 2014 | 9650 | 0.080 |
Why?
|
Stroke Volume | 2 | 2018 | 5460 | 0.080 |
Why?
|
Monocytes | 3 | 2018 | 2570 | 0.080 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2014 | 393 | 0.080 |
Why?
|
United States | 7 | 2021 | 72140 | 0.080 |
Why?
|
Quality of Life | 4 | 2022 | 13286 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 795 | 0.080 |
Why?
|
Cross-Over Studies | 3 | 2005 | 2048 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2882 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7985 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4342 | 0.080 |
Why?
|
Amino Acids | 1 | 2015 | 1713 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1680 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2943 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58681 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8554 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 839 | 0.070 |
Why?
|
Age Distribution | 2 | 2011 | 2882 | 0.070 |
Why?
|
Blood Pressure | 5 | 2007 | 8453 | 0.070 |
Why?
|
Exercise Test | 2 | 2012 | 2121 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2015 | 1370 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2600 | 0.070 |
Why?
|
Linear Models | 2 | 2014 | 5861 | 0.070 |
Why?
|
Mice | 8 | 2021 | 81107 | 0.070 |
Why?
|
Dinucleoside Phosphates | 1 | 2006 | 72 | 0.070 |
Why?
|
Recurrence | 2 | 2016 | 8426 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.070 |
Why?
|
Friedreich Ataxia | 1 | 2007 | 77 | 0.070 |
Why?
|
Chlorophyllides | 1 | 2006 | 54 | 0.070 |
Why?
|
Tomography, Spiral Computed | 1 | 2008 | 273 | 0.070 |
Why?
|
Reference Values | 3 | 2011 | 4919 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4158 | 0.060 |
Why?
|
Sex Distribution | 1 | 2011 | 2283 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.060 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4504 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2011 | 793 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6821 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3046 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11070 | 0.060 |
Why?
|
Hemodynamics | 3 | 2015 | 4159 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2144 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1630 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3671 | 0.060 |
Why?
|
Heart Failure | 3 | 2023 | 11594 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9468 | 0.060 |
Why?
|
Canada | 2 | 2023 | 2111 | 0.060 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1780 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7338 | 0.060 |
Why?
|
Sulfasalazine | 1 | 2024 | 84 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1112 | 0.060 |
Why?
|
Logistic Models | 3 | 2013 | 13276 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1855 | 0.060 |
Why?
|
Plethysmography | 1 | 2004 | 174 | 0.060 |
Why?
|
Nitroprusside | 1 | 2004 | 272 | 0.060 |
Why?
|
Infusions, Intra-Arterial | 1 | 2004 | 221 | 0.060 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 260 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2796 | 0.060 |
Why?
|
Verapamil | 1 | 2004 | 242 | 0.050 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.050 |
Why?
|
Algorithms | 2 | 2016 | 13959 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3384 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6493 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2024 | 163 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1919 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10146 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2014 | 6233 | 0.050 |
Why?
|
Catecholamines | 1 | 2003 | 385 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2275 | 0.050 |
Why?
|
Nuclear Medicine | 1 | 2005 | 236 | 0.050 |
Why?
|
Myocardial Reperfusion | 1 | 2003 | 337 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1401 | 0.050 |
Why?
|
Mitochondria, Heart | 1 | 2003 | 229 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1969 | 0.050 |
Why?
|
Brain Infarction | 1 | 2023 | 290 | 0.050 |
Why?
|
Vena Cava, Superior | 1 | 2022 | 197 | 0.050 |
Why?
|
Forearm | 1 | 2004 | 427 | 0.050 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 195 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 906 | 0.050 |
Why?
|
Myocardial Stunning | 1 | 2001 | 66 | 0.050 |
Why?
|
Myocardial Infarction | 2 | 2012 | 11424 | 0.050 |
Why?
|
Dobutamine | 1 | 2000 | 116 | 0.040 |
Why?
|
Lipoproteins | 2 | 2016 | 881 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 694 | 0.040 |
Why?
|
Pyridines | 1 | 2012 | 2860 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 2115 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2007 | 1846 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2016 | 18942 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1915 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2009 | 1916 | 0.040 |
Why?
|
Scotland | 1 | 2020 | 143 | 0.040 |
Why?
|
Methionine | 1 | 2002 | 569 | 0.040 |
Why?
|
Drug Combinations | 1 | 2006 | 2020 | 0.040 |
Why?
|
Troponin | 2 | 2014 | 500 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2015 | 10417 | 0.040 |
Why?
|
Thyrotropin | 1 | 2003 | 832 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1414 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22006 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12440 | 0.040 |
Why?
|
England | 1 | 2020 | 524 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 625 | 0.040 |
Why?
|
Electrocardiography | 3 | 2012 | 6363 | 0.040 |
Why?
|
Young Adult | 5 | 2016 | 58808 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12876 | 0.040 |
Why?
|
Rest | 1 | 2003 | 914 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2000 | 539 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 609 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2014 | 2925 | 0.040 |
Why?
|
Sex Factors | 2 | 2024 | 10505 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 5917 | 0.030 |
Why?
|
Syndrome | 1 | 2003 | 3262 | 0.030 |
Why?
|
Survival Rate | 1 | 2011 | 12721 | 0.030 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2018 | 418 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2003 | 2359 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1565 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10495 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12870 | 0.030 |
Why?
|
Apolipoproteins E | 2 | 2015 | 1436 | 0.030 |
Why?
|
Nitroglycerin | 1 | 1997 | 328 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 584 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 2015 | 223 | 0.030 |
Why?
|
Dideoxynucleosides | 1 | 2015 | 131 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2007 | 1944 | 0.030 |
Why?
|
Blood Glucose | 2 | 2013 | 6347 | 0.030 |
Why?
|
Ultrasonography | 2 | 2014 | 5952 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2211 | 0.030 |
Why?
|
Progesterone | 1 | 1998 | 742 | 0.030 |
Why?
|
Venae Cavae | 1 | 2013 | 41 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2014 | 96 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2014 | 2825 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2024 | 2209 | 0.030 |
Why?
|
Ligation | 1 | 2014 | 448 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1585 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3709 | 0.030 |
Why?
|
Autoradiography | 1 | 2014 | 730 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2013 | 222 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1174 | 0.030 |
Why?
|
Adolescent | 3 | 2016 | 87888 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 1998 | 1206 | 0.020 |
Why?
|
Sulfonamides | 1 | 2021 | 1973 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 664 | 0.020 |
Why?
|
Cold Temperature | 1 | 2015 | 780 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14354 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 1933 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 282 | 0.020 |
Why?
|
Endarterectomy | 1 | 2011 | 195 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 353 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2014 | 585 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 605 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 461 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 3006 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2012 | 552 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2210 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 393 | 0.020 |
Why?
|
Neutropenia | 1 | 2014 | 884 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7810 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 632 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11152 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1570 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1997 | 2131 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2001 | 3858 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7377 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4087 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1599 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6353 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3302 | 0.020 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2007 | 101 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2007 | 272 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 830 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2007 | 405 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 549 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5892 | 0.020 |
Why?
|
Systole | 1 | 2007 | 936 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 699 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2007 | 930 | 0.010 |
Why?
|
Body Size | 1 | 2007 | 462 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4839 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2880 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2467 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1865 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7225 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 3997 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2252 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1897 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8651 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8503 | 0.010 |
Why?
|
Motor Activity | 1 | 2007 | 2686 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12951 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10112 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2007 | 3806 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23681 | 0.010 |
Why?
|
Postmenopause | 1 | 1998 | 2509 | 0.010 |
Why?
|